RELIGN is a startup company in the heart of Silicon Valley dedicated to innovation in arthroscopy and providing surgeons with the best-in-class product for more efficient outcomes. They are trailblazers in the field of arthroscopy and committed to the radical evolution of resection technology. Leveraging our years of experience, progressive research and development, and surgeon feedback, RELIGN launched the Tricera™ System. Tricera is a revolutionary, advanced system that combines ablation/coagulation, tissue resection, bone cutting, and fluid management into one unique system. RELIGN continues to put a strong emphasis on research and development to work towards providing quality, effective solutions for surgeons to further advance arthroscopic surgery.